| Dr Terry I Finlayson, MD | |
|
2310 N 400 E, Logan, UT 84341-1788 | |
| (435) 787-2000 | |
| (435) 787-1913 |
| Full Name | Dr Terry I Finlayson |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 33 Years |
| Location | 2310 N 400 E, Logan, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316935539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 363309-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intermountain Homecare Ogden | Ogden, UT | Home health agency |
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Acura Pharmaceuticals, Inc. today announced that it has been informed by King Pharmaceuticals Research and Development Inc. (King) that King's New Drug Application (NDA) for ACUROX® (oxycodone HCl) Tablets was accepted for filing by the US Food and Drug Administration (FDA) with a Priority review classification and a Prescription Drug User Fee Act (PDUFA) date of June 17, 2011.
Addressing the nation's continuing poor performance in cancer clinical trial participation, particularly among racial and ethnic minorities and low income groups, will require meaningful public involvement in the design and implementation of clinical trials, according to a landmark report released today.
Teva Pharmaceutical Industries Ltd. announced today that lipegfilgrastim achieved its primary endpoint of reducing the duration of severe neutropenia in a Phase III study designed to evaluate the efficacy and safety of lipegfilgrastim (XM22) compared to pegfilgrastim (Amgen's Neulasta™).
A leading scientific journal in Pakistan, The Journal of Management & Social Science, recently published a paper titled "A New Role for the Military: Preventing Enemies from Arising-Reviving an Ancient Approach to Peace," indicating that the military application of the Transcendental Meditation technique has merit. The paper discusses how militaries worldwide could use the Transcendental Meditation- and TM-Sidhi- program, founded by Maharishi Mahesh Yogi, as a non-religious and scientifically verified way to prevent war and terrorism. When used in a military context, these meditation practices are known as Invincible Defense Technology (IDT).
How the body regulates blood pressure in response to daily stress is the focus of a study geared toward helping people whose pressure is out of control.
› Verified 1 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Acura Pharmaceuticals, Inc. today announced that it has been informed by King Pharmaceuticals Research and Development Inc. (King) that King's New Drug Application (NDA) for ACUROX® (oxycodone HCl) Tablets was accepted for filing by the US Food and Drug Administration (FDA) with a Priority review classification and a Prescription Drug User Fee Act (PDUFA) date of June 17, 2011.
Addressing the nation's continuing poor performance in cancer clinical trial participation, particularly among racial and ethnic minorities and low income groups, will require meaningful public involvement in the design and implementation of clinical trials, according to a landmark report released today.
Teva Pharmaceutical Industries Ltd. announced today that lipegfilgrastim achieved its primary endpoint of reducing the duration of severe neutropenia in a Phase III study designed to evaluate the efficacy and safety of lipegfilgrastim (XM22) compared to pegfilgrastim (Amgen's Neulasta™).
A leading scientific journal in Pakistan, The Journal of Management & Social Science, recently published a paper titled "A New Role for the Military: Preventing Enemies from Arising-Reviving an Ancient Approach to Peace," indicating that the military application of the Transcendental Meditation technique has merit. The paper discusses how militaries worldwide could use the Transcendental Meditation- and TM-Sidhi- program, founded by Maharishi Mahesh Yogi, as a non-religious and scientifically verified way to prevent war and terrorism. When used in a military context, these meditation practices are known as Invincible Defense Technology (IDT).
How the body regulates blood pressure in response to daily stress is the focus of a study geared toward helping people whose pressure is out of control.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Terry I Finlayson, MD 2310 N 400 E, Logan, UT 84341-1796 Ph: (435) 787-2000 | Dr Terry I Finlayson, MD 2310 N 400 E, Logan, UT 84341-1788 Ph: (435) 787-2000 |
News Archive
Acura Pharmaceuticals, Inc. today announced that it has been informed by King Pharmaceuticals Research and Development Inc. (King) that King's New Drug Application (NDA) for ACUROX® (oxycodone HCl) Tablets was accepted for filing by the US Food and Drug Administration (FDA) with a Priority review classification and a Prescription Drug User Fee Act (PDUFA) date of June 17, 2011.
Addressing the nation's continuing poor performance in cancer clinical trial participation, particularly among racial and ethnic minorities and low income groups, will require meaningful public involvement in the design and implementation of clinical trials, according to a landmark report released today.
Teva Pharmaceutical Industries Ltd. announced today that lipegfilgrastim achieved its primary endpoint of reducing the duration of severe neutropenia in a Phase III study designed to evaluate the efficacy and safety of lipegfilgrastim (XM22) compared to pegfilgrastim (Amgen's Neulasta™).
A leading scientific journal in Pakistan, The Journal of Management & Social Science, recently published a paper titled "A New Role for the Military: Preventing Enemies from Arising-Reviving an Ancient Approach to Peace," indicating that the military application of the Transcendental Meditation technique has merit. The paper discusses how militaries worldwide could use the Transcendental Meditation- and TM-Sidhi- program, founded by Maharishi Mahesh Yogi, as a non-religious and scientifically verified way to prevent war and terrorism. When used in a military context, these meditation practices are known as Invincible Defense Technology (IDT).
How the body regulates blood pressure in response to daily stress is the focus of a study geared toward helping people whose pressure is out of control.
› Verified 1 days ago
Bryan C King, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1300 N 500 E, #130, Logan, UT 84341 Phone: 435-716-2800 | |
Dr. Joseph Jay Stuart, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-716-2800 | |
Dr. Gregory J Hicken, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2310 N 400 E, Ste A, Logan, UT 84341 Phone: 435-787-2000 Fax: 435-787-1913 | |
Edwin Marlowe Goble, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 274 N Main St, Logan, UT 84321 Phone: 435-753-1600 Fax: 435-753-9521 | |
Dr. Keith J Nelson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2310 N 400 E, Ste A, Logan, UT 84341 Phone: 435-787-2000 Fax: 435-787-1913 | |
Dr. Brian A. Vernon, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 630 E 1400 N Ste 118, Logan, UT 84341 Phone: 435-799-7953 Fax: 435-514-7977 |